Cheryl Gault
Chief Operating Officer at Rapport Therapeutics, Inc.
Net worth: 2 514 $ as of 30/04/2024
Cheryl Gault active positions
| Companies | Position | Start | End |
|---|---|---|---|
Rapport Therapeutics, Inc.
 Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Chief Operating Officer | 07/09/2023 | - |
Career history of Cheryl Gault
Former positions of Cheryl Gault
| Companies | Position | Start | End |
|---|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Chief Operating Officer | 01/01/2021 | 28/07/2023 |
| Corporate Officer/Principal | 01/05/2020 | 01/01/2021 | |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2011 | 01/04/2019 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Sales & Marketing | - | - |
Training of Cheryl Gault
| Boston College | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |
- Stock Market
- Insiders
- Cheryl Gault
- Experience